WO2003002529A3 - Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone - Google Patents
Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone Download PDFInfo
- Publication number
- WO2003002529A3 WO2003002529A3 PCT/US2002/022085 US0222085W WO03002529A3 WO 2003002529 A3 WO2003002529 A3 WO 2003002529A3 US 0222085 W US0222085 W US 0222085W WO 03002529 A3 WO03002529 A3 WO 03002529A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymorphs
- quinolinone
- tetrazol
- butoxy
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002322456A AU2002322456A1 (en) | 2001-06-29 | 2002-06-28 | Polymorphic forms of 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-3, 4-dihydro-2(1h)-quinolinone |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/896,184 US6531603B1 (en) | 2001-06-29 | 2001-06-29 | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US09/896,800 US6596871B2 (en) | 2001-06-29 | 2001-06-29 | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US09/896,185 | 2001-06-29 | ||
US09/896,184 | 2001-06-29 | ||
US09/896,185 US20030045548A1 (en) | 2001-06-29 | 2001-06-29 | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-YL)butoxy]-3,4-dihydro-2(1H)-quinolinone |
US09/896,800 | 2001-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003002529A2 WO2003002529A2 (en) | 2003-01-09 |
WO2003002529A3 true WO2003002529A3 (en) | 2003-05-08 |
Family
ID=27420565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/022085 WO2003002529A2 (en) | 2001-06-29 | 2002-06-28 | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002322456A1 (en) |
WO (1) | WO2003002529A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4277479A (en) * | 1978-09-01 | 1981-07-07 | Otsuka Pharmaceutical Co., Ltd. | Tetrazolylalkoxycarbostyril derivatives and pharmaceutical compositions containing them |
US4728653A (en) * | 1984-05-29 | 1988-03-01 | Pfizer Inc. | 6-heteroaryl quinolone inotropic agents |
US6388080B1 (en) * | 2001-06-29 | 2002-05-14 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
-
2002
- 2002-06-28 WO PCT/US2002/022085 patent/WO2003002529A2/en not_active Application Discontinuation
- 2002-06-28 AU AU2002322456A patent/AU2002322456A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4277479A (en) * | 1978-09-01 | 1981-07-07 | Otsuka Pharmaceutical Co., Ltd. | Tetrazolylalkoxycarbostyril derivatives and pharmaceutical compositions containing them |
US4728653A (en) * | 1984-05-29 | 1988-03-01 | Pfizer Inc. | 6-heteroaryl quinolone inotropic agents |
US6388080B1 (en) * | 2001-06-29 | 2002-05-14 | Grayson Walker Stowell | Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
Also Published As
Publication number | Publication date |
---|---|
AU2002322456A1 (en) | 2003-03-03 |
WO2003002529A2 (en) | 2003-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003209119A1 (en) | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors | |
IL164292A0 (en) | Quinoline and isoquinoline derivatives, method forthe production thereof and use thereof as anti-in flammatory agents | |
WO2005058835A3 (en) | Methods of preparing aripiprazole crystalline forms | |
RS20070205A (en) | 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics | |
WO2006121767A3 (en) | 4-aminoquinoline compounds for treating virus-related conditions | |
WO2006004636A3 (en) | Fused heterocyclic kinase inhibitors | |
WO2009076141A3 (en) | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
WO2007033266A3 (en) | Dipeptidyl peptidase inhibitors for treating diabetis | |
EE200100167A (en) | 4-amino-substituted 2-substituted 1,2,3,4-tetrahydroquinolines as CETP inhibitors | |
TNSN07434A1 (en) | Crystalline and other forms of 4-amino-5-fluoro-3- [6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts | |
EP1837331A3 (en) | New crystalline aripiprazole salts and processes for preparation and purification thereof | |
BRPI0407904A (en) | process for the preparation of useful 5 - [(r) -2- (5,6-diethyl-indan-2-ylain) -1-hydroxy-ethyl] -8-hydroxy (1h) -quinolin-2-one salt as an adrenoceptor agonist | |
HRP20050855A2 (en) | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them | |
WO2009149259A3 (en) | Processes for preparing tetrahydroisoquinolines | |
IL179709A0 (en) | 4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compositions containing same | |
WO2005075427A3 (en) | Montelukast sodium polymorphs | |
WO2003022209A3 (en) | Crystalline forms of valacyclovir hydrochloride | |
WO2007023115A3 (en) | P38 map kinase inhibitors and methods for using the same | |
WO2004106322A3 (en) | Polymorphs of aripiprazole | |
WO2004073628A3 (en) | Novel compounds | |
PT1625116E (en) | Process for the preparation of carbostyril derivatives,such as aripiprazole and its intermediates | |
WO2004050036A3 (en) | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents | |
MY145540A (en) | Chemical process | |
WO2003002529A3 (en) | Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone | |
AU2003224482A1 (en) | Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |